Sigma-Aldrich Posts 5 Percent Revenue Growth for Q4 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter revenues increased 5 percent, or 3 percent organically, but it fell short of Wall Street's expectations.

The St. Louis-based research and chemical products firm reported total revenues of $610 million for the three-month period ended Dec. 31, compared to $582 million for the fourth quarter of 2010. Analysts, on average, had expected revenues of $626.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.